Chinese Journal of Nursing ›› 2021, Vol. 56 ›› Issue (7): 1072-1078.DOI: 10.3761/j.issn.0254-1769.2021.07.020
• Evidence Synthesis Research • Previous Articles Next Articles
XIAO Xingting(),WANG Xian(),WANG Yan,MU Wenfang,ZHU Weikang
Received:
2021-01-08
Online:
2021-07-15
Published:
2021-06-29
Contact:
Xian WANG
通讯作者:
王娴
作者简介:
肖星婷:女,本科(硕士在读),E-mail: 基金资助:
XIAO Xingting,WANG Xian,WANG Yan,MU Wenfang,ZHU Weikang. The best evidence summary for prevention and nursing care of chemotherapy-induced alopecia in breast cancer patients[J]. Chinese Journal of Nursing, 2021, 56(7): 1072-1078.
肖星婷,王娴,王燕,穆文方,朱为康. 乳腺癌患者化疗所致脱发预防及护理的证据总结[J]. 中华护理杂志, 2021, 56(7): 1072-1078.
Add to citation manager EndNote|Ris|BibTeX
URL: http://zh.zhhlzzs.com/EN/10.3761/j.issn.0254-1769.2021.07.020
[1] | Latest global cancer data:Cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020[EB/OL]. ( 2020- 12- 15)[2020- 12- 20]. https://www.iarc.fr/fr/news-events/la-test-global-cancer-data-cancer-burden-rises-to-19-3-million-new-cases-and-10-0-million-cancer-deaths-in-2020/ |
[2] |
Runowicz CD, Leach CR, Henry NL, et al. American cancer so-ciety/American society of clinical oncology breast cancer survivorship care guideline[J]. J Clin Oncol, 2016, 34(6):611-635.
DOI PMID |
[3] | 褚彦香, 王颖, 熊欢. 分级管理方案在乳腺癌患者化疗所致恶心呕吐中的应用[J]. 中华护理杂志, 2019, 54(12):1815-1819. |
Chu YX, Wang Y, Xiong H. Clinical practice of grading management scheme for chemotherapy induced nausea and vomiting in breast cancer patients[J]. Chin J Nurs, 2019, 54(12):1815-1819. | |
[4] | 王坤, 陈长英, 艾建赛, 等. 正念减压疗法对乳腺癌患者化疗期间疲乏及睡眠质量的影响[J]. 中华护理杂志, 2017, 52(5):518-523. |
Wang K, Chen CY, Ai JS, et al. The effects of mindfulness-based stress reduction on fatigue and sleep quality for breast cancer patients undergoing chemotherapy[J]. Chin J Nurs, 2017, 52(5):518-523. | |
[5] | Macduff C, Mackenzie T, Hutcheon A, et al. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel[J]. Eur J Cancer Care(Engl), 2003, 12(2):154-161. |
[6] |
Trüeb RM. Chemotherapy-induced alopecia[J]. Curr Opin Support Palliat Care, 2010, 4(4):281-284.
DOI URL |
[7] |
Rossi A, Fortuna MC, Caro G, et al. Chemotherapy-induced alo-pecia management:clinical experience and practical advice[J]. J Cosmet Dermatol, 2017, 16(4):537-541.
DOI URL |
[8] | 张阳, 田丽, 陈长英. 化疗致脱发对癌症病人治疗依从性的影响及护理进展[J]. 护理研究, 2017, 31(29):3643-3646. |
Zhang Y, Tian L, Chen CY. Influence and nursing progress of chemotherapy-induced alopecia on treatment compliance of cancer patients[J]. Chin Nurs Res, 2017, 31(29):3643-3646. | |
[9] | 马玲, 王世平, Joanne Chung. 乳腺癌患者相关症状及其对生活质量的影响研究[J]. 中国循证医学杂志, 2007, 7(3):169-174. |
Ma L, Wang SP, Joanne Chung. A survey on correlative symptoms and its influence on quality of life in breast cancer patients[J]. Chin J Evid-Based Med, 2007, 7(3):169-174. | |
[10] |
Hesketh PJ, Batchelor D, Golant M, et al. Chemotherapy-indu-ced alopecia:psychosocial impact and therapeutic approaches[J]. Support Care Cancer, 2004, 12(8):543-549.
PMID |
[11] |
Dunnill CJ, Al-Tameemi W, Collett A, et al. A clinical and biological guide for understanding chemotherapy-induced alopecia and its prevention[J]. Oncologist, 2018, 23(1):84-96.
DOI URL |
[12] |
Williams LA, Ginex PK, Ebanks GL, et al. ONS guidelines for cancer treatment-related skin toxicity[J]. Oncol Nurs Forum, 2020, 47(5):539-556.
DOI PMID |
[13] |
Rugo HS, Voigt J. Scalp hypothermia for preventing alopecia during chemotherapy.A systematic review and meta-analysis of randomized controlled trials[J]. Clin Breast Cancer, 2018, 18(1):19-28.
DOI URL |
[14] | 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志, 2019, 29(8):609-680. |
Breast Cancer Professional Committee of Chinese Anti-Cancer Association. Guideline and standard for the diagnosis and treatment of breast cancer by Chinese anti-cancer association(2019 edition)[J]. China oncol J, 2019, 29(8):609-680. | |
[15] |
Newhouse RP. Diffusing confusion among evidence-based prac-tice,quality improvement,and research[J]. J Nurs Adm, 2007, 37(10):432-435.
DOI URL |
[16] |
Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ:advan-cing guideline development,reporting,and evaluation in health care[J]. Prev Med, 2010, 51(5):421-424.
DOI PMID |
[17] | 顾莺, 张慧文, 周英凤, 等. JBI循证卫生保健中心关于不同类型研究的质量评价工具:系统评价的方法学质量评价[J]. 护士进修杂志, 2018, 33(8):701-703. |
Gu Y, Zhang HW, Zhou YF, et al. JBI evidence-based health center’s quality assessment tool for different types of research-the quality evaluation of diagnostic and economic eva-luation[J]. J Nurses Train, 2018, 33(8):701-703. | |
[18] | Thill M, Liedtke C, Müller V, et al. AGO recommendations for the diagnosis and treatment of patients with advanced and metastatic breast cancer:update 2018[J]. Breast Care(Basel), 2018, 13(3):209-215. |
[19] |
Lyman GH, Greenlee H, Bohlke K, et al. Integrative therapies during and after breast cancer treatment:ASCO endorsement of the SIO clinical practice guideline[J]. J Clin Oncol, 2018, 36(25):2647-2655.
DOI PMID |
[20] |
Messenger AG, McKillop J, Farrant P, et al. British Association of Dermatologists’ guidelines for the management of alopecia areata 2012[J]. Br J Dermatol, 2012, 166(5):916-926.
DOI URL |
[21] | Lacouture ME, Anadkat MJ, Bensadoun RJ, et al. Clinical prac-tice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities[J]. Support Care Can-cer, 2011, 19(8):1079-1095. |
[22] | SIGN. Treatment of primary breast cancer[EB/OL]. ( 2013- 09- 11)[2020- 12- 20]. https://www.sign.ac.uk/our-guidelines/treatment-of-primary-breast-cancer/ |
[23] |
Marks DH, Qureshi A, Friedman A. Evaluation of prevention interventions for taxane-induced dermatologic adverse events:a systematic review[J]. JAMA Dermatol, 2018, 154(12):1465-1472.
DOI URL |
[24] |
Rubio-Gonzalez B, Juhász M, Fortman J, et al. Pathogenesis and treatment options for chemotherapy-induced alopecia:a systematic review[J]. Int J Dermatol, 2018, 57(12):1417-1424.
DOI PMID |
[25] |
Shin H, Jo SJ, Kim DH, et al. Efficacy of interventions for prevention of chemotherapy-induced alopecia:a systematic review and meta-analysis[J]. Int J Cancer, 2015, 136(5):E442-E454.
DOI URL |
[26] | Wu Y, Li W, Stephenson M, et al. Pre-treatment assessment for patients with breast cancer undergoing chemotherapy:a best practice implementation project[J]. JBI Evid Synth, 2020, 18(1):212-223. |
[27] |
Cury-Martins J, Eris APM, Abdalla CMZ, et al. Management of dermatologic adverse events from cancer therapies:recommendations of an expert panel[J]. An Bras Dermatol, 2020, 95(2):221-237.
DOI PMID |
[28] |
Chu CY, Chen KY, Wen-Cheng Chang J, et al. Taiwanese Der-matological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities[J]. J Formos Med Assoc, 2017, 116(6):413-423.
DOI URL |
[29] | Gutzmer R, Becker JC, Enk A, et al. Management of cutaneous side effects of EGFR inhibitors:recommendations from a German expert panel for the primary treating physician[J]. JDDG:J Der Deutschen Dermatol Gesellschaft, 2011, 9(3):195-202. |
[30] | 王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967. |
Wang CQ, Hu Y. JBI evidence pre-classification and evidence rank system(2014 Edition)[J]. J Nurses Train, 2015, 30(11):964-967. | |
[31] |
Dean JC, Salmon SE, Griffith KS. Prevention of doxorubicin-induced hair loss with scalp hypothermia[J]. N Engl J Med, 1979, 301(26):1427-1429.
DOI URL |
[32] |
Cho J, Choi EK, Kim IR, et al. Development and validation of Chemotherapy-induced Alopecia Distress Scale(CADS) for breast cancer patients[J]. Ann Oncol, 2014, 25(2):346-351.
DOI PMID |
[33] | 张青月. 中文版乳腺癌化疗脱发困扰量表的信效度检验及其临床应用[D]. 天津:天津医科大学, 2018. |
Zhang QY. Psychometric validity and application of the Chinese version of chemotherapy-induced alopecia distress scale for breast cancer[D]. Tianjin:Tianjin Medical University, 2018. | |
[34] | 从维莲. 化疗脱发困扰量表的汉化修订及在乳腺癌患者中的应用[D]. 广州:南方医科大学, 2020. |
Cong WL. Localization,revision and application of the chemo-therapy-induced alopecia distress scale in patients with breast cancer[D]. Guangzhou:Southern Medical University, 2020. | |
[35] |
Prochilo T, Huscher A, Andreis F, et al. Hair loss prevention by a scalp cooling device in early breast cancer patients:the poliambulanza preliminary experience[J]. Rev Recent Clin Trials, 2019, 14(1):66-71.
DOI PMID |
[36] |
Pliskow B, Mitra K, Kaya M. Simulation of scalp cooling by external devices for prevention of chemotherapy-induced alopecia[J]. J Therm Biol, 2016, 56:31-38.
DOI URL |
[37] | 张青月, 李莹, 吴婷, 等. 化妆美容在乳腺癌化疗患者中的应用效果[J]. 中国护理管理, 2020, 20(4):588-592. |
Zhang QY, Li Y, Wu T, et al. Effects of cosmetic interventions on breast cancer patients undergoing chemotherapy[J]. Chin Nurs Manag, 2020, 20(4):588-592. | |
[38] | 张佳媛, 周郁秋, 张全志, 等. 正念减压疗法对乳腺癌患者知觉压力及焦虑抑郁水平的影响[J]. 中华护理杂志, 2015, 50(2):189-193. |
Zhang JY, Zhou YQ, Zhang QZ, et al. The effect of mindfulness-based stress reduction on perceived stress,anxiety and depression in breast cancer patients[J]. Chin J Nurs, 2015, 50(2):189-193. | |
[39] | 朱文敏, 魏小龙. 非药物干预方法对乳腺癌患者康复效果的网状Meta分析[J]. 中华护理杂志, 2020, 55(6):862-867. |
Zhu WM, Wei XL. A comparative study on the rehabilitation effects of non-pharmacological interventions in patients with Breast cancer:a network meta-analysis[J]. Chin J Nurs, 2020, 55(6):862-867. |
[1] | SHEN Qiaoqiao, FENG Xiangang, LIANG Yunyi, ZUO Qianqian, ZHANG Zhengmin, GAO Yulin. Quality evaluation of clinical practice guidelines on perinatal bereavement care:a systematic review [J]. Chinese Journal of Nursing, 2021, 56(9): 1329-1334. |
[2] | LI Miaomiao, XIONG Yu, LUO Jian. Evidence summary of nutritional support in patients with inflammatory bowel disease [J]. Chinese Journal of Nursing, 2021, 56(9): 1394-1400. |
[3] | XU Niying, REN Xinyan, WANG Xixi, SHEN Rui, GAI Jiaxing, WANG Junjie. Evidence summary of management of feeding difficulty in people with dementia [J]. Chinese Journal of Nursing, 2021, 56(9): 1401-1407. |
[4] | WANG Yu, XU Yuan, WANG Xiaojie, SUN Jianhua, MA Yufen, PANG Dong, ZHU Liyun, LIU Ge, CAO Jing, LU Qiaodan, WU Xinjuan. Evidence summary for prevention of deep venous thrombosis in patients after joint replacement [J]. Chinese Journal of Nursing, 2021, 56(9): 1408-1414. |
[5] | WEN Cuiju,WANG Yueni,SUN Hongjuan,YU Xinying. Symptom clusters and the effects on quality of life among breast cancer patients receiving aromatase inhibitors [J]. Chinese Journal of Nursing, 2021, 56(8): 1201-1207. |
[6] | GONG Beibei,MI Yuanyuan,WEI Caiyun,HUANG Haimei,WU Jinyan,YU Mingliu,LIU Ningmei,ZHU Zheng. Evidence summary of sputum collection methods for patients with pulmonary tuberculosis [J]. Chinese Journal of Nursing, 2021, 56(8): 1229-1235. |
[7] | TAO Guofang,BAO Yangjuan,YANG Su,XING Meiyuan,SONG Yunlian,HUANG Lihua. Evidence summary for the management of home oxygen therapy in patients with chronic obstructive pulmonary disease [J]. Chinese Journal of Nursing, 2021, 56(7): 983-990. |
[8] | Internal Medicine Nursing Committee of Chinese Nursing Association, Writing Committee:MAO Yanjun, ZHANG Su, ZHANG Hongmei. Clinical practice guideline for nursing management of iodinated contrast media extravasation [J]. Chinese Journal of Nursing, 2021, 56(7): 1008-1008. |
[9] | NI Yebin,CHEN Yamei,ZHU Xiaoping,WANG Lu,WANG Jing,ZHANG Lin,CHEN Shujuan,LIN Mengyue,ZHU Zheng,ZHOU Yingfeng,XING Weijie. Evidence summary for management of perioperative blood glucose in patients with diabetes mellitus [J]. Chinese Journal of Nursing, 2021, 56(7): 1079-1085. |
[10] | WANG Xiaojiao,GU Chunyi,ZHANG Zheng,MIN Hui,GUO Lin. Evidence summary of management of non-pharmacological labor analgesia for women with trial of labor [J]. Chinese Journal of Nursing, 2021, 56(7): 1086-1092. |
[11] | XU Yuanyuan,SHI Guangling,ZHANG Yanhong,XU Jianzhen,LIU Juan,JIANG Xuejuan,DU Haiyan. Evidence-based practice in prevention of fecal incontinence associated dermatitis in ICU patients [J]. Chinese Journal of Nursing, 2021, 56(6): 811-817. |
[12] | LI Qingqing,NI Jianfen,FANG Qunying,WU Wanying. Construction and preliminary application of a symptom assessment scale for breast cancer patients with endocrine therapy [J]. Chinese Journal of Nursing, 2021, 56(6): 880-886. |
[13] | XU Rong,WANG Hui,YANG Weimei,WANG Lan,YANG Xueke,XIAO Yaru,CHEN Yushuang,QU Xi,DAI Ling,QU Jia. Evidence summary of patient identification [J]. Chinese Journal of Nursing, 2021, 56(6): 921-928. |
[14] | SHI Zhiyi,LU Ying,XING Liyuan,LIU Weihua,WANG Shujing,WANG Zhenzhen,ZHANG Hongmei. Evidence summary for prevention and management of pregnancy-related low back pain [J]. Chinese Journal of Nursing, 2021, 56(6): 934-941. |
[15] | ZHANG Chenglin,LI Qinghe,WU Cuigan,ZHANG Jing. Research progress on an assessment tool of patient-reported outcomes for breast cancer patients [J]. Chinese Journal of Nursing, 2021, 56(6): 948-951. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||